A Comparative Study of Growth Kinetics, In Vitro Differentiation Potential and Molecular Characterization of Fetal Adnexa Derived Caprine Mesenchymal Stem Cells
Overview
Authors
Affiliations
The present study was conducted with an objective of isolation, in vitro expansion, growth kinetics, molecular characterization and in vitro differentiation of fetal adnexa derived caprine mesenchymal stem cells. Mid-gestation gravid caprine uteri (2-3 months) were collected from abattoir to derive mesenchymal stem cells (MSCs) from fetal adnexa {amniotic fluid (cAF), amniotic sac (cAS), Wharton's jelly (cWJ) and cord blood (cCB)} and expanded in vitro. These cultured MSCs were used at the 3rd passage (P3) to study growth kinetics, localization as well as molecular expression of specific surface antigens, pluripotency markers and mesenchymal tri-lineage differentiation. In comparison to cAF and cAS MSCs, cWJ and cCB MSCs showed significantly (P<0.05) higher clonogenic potency, faster growth rate and low population doubling (PDT) time. All the four types of MSCs were positive for alkaline phosphatase (AP) and differentiated into chondrogenic, osteogenic, and adipogenic lineages. These stem cells expressed MSC surface antigens (CD73, CD90 and CD105) and pluripotency markers (Oct4, Sox2, Nanog, KLF, cMyc, FoxD3) but did not express CD34, a hematopoietic stem cell marker (HSC) as confirmed by RT-PCR, immunocytochemistry and flow cytometric analysis. The relative mRNA expression of MSC surface antigens (CD73, CD90 and CD105) was significantly (P<0.05) higher in cWJ MSCs compared to the other cell lines. The mRNA expression of Oct4 was significantly (P<0.05) higher in cWJ, whereas mRNA expression of KLF and cMyc was significantly (P<0.05) higher in cWJ and cAF than that of cAS and cCB. The comparative assessment revealed that cWJ MSCs outperformed MSCs from other sources of fetal adnexa in terms of growth kinetics, relative mRNA expression of surface antigens, pluripotency markers and tri-lineage differentiation potential, hence, these MSCs could be used as a preferred source for regenerative medicine.
Mesenchymal Stem Cells Isolated from Equine Hair Follicles Using a Method of Air-Liquid Interface.
Li H, Xiong S, Masieri F, Monika S, Lethaus B, Savkovic V Stem Cell Rev Rep. 2023; 19(8):2943-2956.
PMID: 37733199 PMC: 10661790. DOI: 10.1007/s12015-023-10619-w.
Jain M, Singh N, Fatima R, Nachanekar A, Pradhan M, Nityanand S Biology (Basel). 2023; 12(4).
PMID: 37106752 PMC: 10136182. DOI: 10.3390/biology12040552.
Swistowska M, Gil-Kulik P, Czop M, Wieczorek K, Macheta A, Petniak A Int J Mol Sci. 2023; 24(4).
PMID: 36835597 PMC: 9962001. DOI: 10.3390/ijms24044186.
Pochon C, Notarantonio A, Laroye C, Reppel L, Bensoussan D, Bertrand A J Cell Mol Med. 2022; 26(5):1339-1350.
PMID: 35088933 PMC: 8899189. DOI: 10.1111/jcmm.17105.
Alves J, Rossetto R, Fernandes C, Montenegro A, Marques I, Cavalcanti C Vet Res Commun. 2021; 46(1):169-182.
PMID: 34625865 DOI: 10.1007/s11259-021-09843-x.